Skip to main content
IONIS PHARMACEUTICALS INC logo

IONIS PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · IONS ISIN · US4622221004 LEI · 549300SI4ZGLG0BLUZ92 US Manufacturing
Open in API
Filings indexed 1,797 across all filing types
Latest filing 2022-10-18 Director's Dealing
Country US United States of America
Listing US IONS

About IONIS PHARMACEUTICALS INC

https://www.ionis.com/

Ionis Pharmaceuticals, Inc. is a biopharmaceutical company that discovers and develops RNA- and DNA-targeted therapeutics. Leveraging its expertise in antisense technology and a deep understanding of genetics, the company creates novel medicines designed to treat a wide range of serious diseases. Its development pipeline and marketed products primarily address neurologic and cardiometabolic disorders, as well as other areas with high unmet patient needs, including rare diseases. The company's approach aims to provide new solutions for complex and often intractable conditions by targeting the root cause of disease at the genetic level.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2022-10-18 English
PRIMARY DOCUMENT
Director's Dealing
2022-10-18 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement, specifically a lease agreement for a new building. There are no financial statements or detailed financial performance data included. The document is not an annual or quarterly report, nor is it an earnings release or management discussion. It is not a proxy, voting result, or governance document. The primary purpose is to disclose a material contract event. According to the filing definitions, such announcements of material agreements are typically filed as Current Reports under Form 8-K, which fall under Regulatory Filings (RNS) in this classification scheme as a fallback category for miscellaneous filings that do not fit other specific categories. The document length (6599 characters) and content confirm it is a full filing, not just a brief announcement or certification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-10-12 English
PRIMARY DOCUMENT
Director's Dealing
2022-09-21 English
PRIMARY DOCUMENT
Director's Dealing
2022-09-12 English
PRIMARY DOCUMENT
Director's Dealing
2022-09-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.